These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35412135)

  • 1. Endogenous Peptide Inhibitors of HIV Entry.
    Harms M; Hayn M; Zech F; Kirchhoff F; Münch J
    Adv Exp Med Biol; 2022; 1366():65-85. PubMed ID: 35412135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.
    Reeves JD; Hibbitts S; Simmons G; McKnight A; Azevedo-Pereira JM; Moniz-Pereira J; Clapham PR
    J Virol; 1999 Sep; 73(9):7795-804. PubMed ID: 10438870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells.
    Schols D; De Clercq E
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2203-5. PubMed ID: 9747729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin peptides block the entry of human immunodeficiency virus (HIV).
    Zou MX; Liu HY; Haraguchi Y; Soda Y; Tatemoto K; Hoshino H
    FEBS Lett; 2000 May; 473(1):15-8. PubMed ID: 10802050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
    Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.
    Zhang Y; Lou B; Lal RB; Gettie A; Marx PA; Moore JP
    J Virol; 2000 Aug; 74(15):6893-910. PubMed ID: 10888629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses.
    Shimizu N; Soda Y; Kanbe K; Liu HY; Mukai R; Kitamura T; Hoshino H
    J Virol; 2000 Jan; 74(2):619-26. PubMed ID: 10623723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV entry inhibitors revisited.
    Leonard JT; Roy K
    Curr Med Chem; 2006; 13(8):911-34. PubMed ID: 16611075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short amino acid sequence containing tyrosine in the N-terminal region of G protein-coupled receptors is critical for their potential use as co-receptors for human and simian immunodeficiency viruses.
    Shimizu N; Tanaka A; Oue A; Mori T; Apichartpiyakul C; Hoshino H
    J Gen Virol; 2008 Dec; 89(Pt 12):3126-3136. PubMed ID: 19008402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
    Panos G; Watson DC
    Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short communication: identification of the conformational requirement for the specificities of coreceptors for human and simian immunodeficiency viruses.
    Shimizu N; Tanaka A; Jinno-Oue A; Mori T; Ohtsuki T; Hoshino H
    AIDS Res Hum Retroviruses; 2010 Mar; 26(3):321-8. PubMed ID: 20334567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor.
    Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE
    Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.
    Zhang L; He T; Talal A; Wang G; Frankel SS; Ho DD
    J Virol; 1998 Jun; 72(6):5035-45. PubMed ID: 9573273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor.
    Jiang X; Feyertag F; Meehan CJ; McCormack GP; Travers SA; Craig C; Westby M; Lewis M; Robertson DL
    J Virol; 2015 Nov; 89(22):11457-72. PubMed ID: 26339063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 tropism and inhibitors of viral entry: clinical implications.
    Weber J; Piontkivska H; Quiñones-Mateu ME
    AIDS Rev; 2006; 8(2):60-77. PubMed ID: 16848274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of HIV type 2 primary isolates to CCR5 and CXCR4 monoclonal antibodies, ligands, and small molecule inhibitors.
    Espirito-Santo M; Santos-Costa Q; Calado M; Dorr P; Azevedo-Pereira JM
    AIDS Res Hum Retroviruses; 2012 May; 28(5):478-85. PubMed ID: 21902586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.
    Chen Z; Zhou P; Ho DD; Landau NR; Marx PA
    J Virol; 1997 Apr; 71(4):2705-14. PubMed ID: 9060623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.
    Amara A; Gall SL; Schwartz O; Salamero J; Montes M; Loetscher P; Baggiolini M; Virelizier JL; Arenzana-Seisdedos F
    J Exp Med; 1997 Jul; 186(1):139-46. PubMed ID: 9207008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.